Subacute Cutaneous Lupus Erythematosus

• CLINICAL_TRIALS research · 2026-04-23
  Clinical Trial Update: A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus [Phase 2, Phase 3]

  Biogen is conducting a two-part Phase 2/3 trial evaluating litifilimab (BIIB059) for adults with active cutaneous lupus erythematosus; the s…

• CLINICAL_TRIALS research · 2026-04-21
  Clinical Trial Update: A Study to Assess the Safety, Tolerability, and Efficacy of IMVT-1402 in Participants With Cutaneous Lupus Erythematosus (CLE) [Phase 2]

  A Phase 2 clinical trial evaluating safety, tolerability, and efficacy of IMVT-1402 in adults with subacute and chronic cutaneous lupus eryt…

• CLINICAL_TRIALS research · 2026-04-17
  Clinical Trial Update: A Long-Term Extension Study to Learn More About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus [Phase 3]

  This clinical trial update describes a long-term extension study evaluating the safety of Litifilimab (BIIB059) injections and its potential…

• CLINICAL_TRIALS trial_result · 2026-03-30
  Clinical Trial Update: A Study to Continue the Administration of Deucravacitinib in Participants With Systemic Lupus Erythematosus (SLE) or Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) Who Have Completed Study IM011074 or Study IM011132 [Phase 4]

  Phase 4 clinical trial update indicating that deucravacitinib is being studied in participants with systemic lupus erythematosus (SLE) or di…

• CLINICAL_TRIALS research · 2026-03-11
  Clinical Trial Update: A Phase III Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus Erythematosus [Phase 3]

  A Phase 3 trial evaluating anifrolumab for chronic and/or subacute cutaneous lupus erythematosus is currently recruiting.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2025-09-10
  Clinical Trial Update: A Study to Evaluate Efficacy and Safety of Deucravacitinib in Participants With Active Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) [Phase 2]

  Phase 2 study evaluating the efficacy and safety of deucravacitinib in active discoid lupus erythematosus and subacute cutaneous lupus eryth…

• CLINICAL_TRIALS trial_result · 2020-06-23
  Clinical Trial Update: To Evaluate the Preliminary Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of CC-11050 in Subjects With Discoid Lupus Erythematosus and Subacute Cutaneous Lupus Erythematosus [Phase 2]

  Phase 2 clinical trial assessing CC-11050 for safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy in discoid and subacute…

• CLINICAL_TRIALS trial_result · 2017-03-22
  Clinical Trial Update: Safety and Efficacy of KRP203 in Subacute Cutaneous Lupus Erythematosus [Phase 2]

  Phase 2 trial evaluating the safety and efficacy of KRP203 in Subacute Cutaneous Lupus Erythematosus has completed.

• CLINICAL_TRIALS trial_result · 2016-09-28
  Clinical Trial Update: Pilot Tape Harvesting Study

  Biogen completed a pilot tape-harvesting study evaluating tape-stripping methods in subjects with Atopic Dermatitis, Discoid Lupus Erythemat…